Loading…
Analysis of (R)- and (S)-[11C]rolipram Kinetics in Canine Myocardium for the Evaluation of Phosphodiesterase-4 with PET
Purpose ( R )-[ 11 C]rolipram and ( S )-[ 11 C]rolipram have been proposed to investigate phosphodiesterase-4 and, indirectly, cAMP-mediated signaling with PET. This study assessed binding of these tracers to phosphodiesterase-4 in canine myocardium. Procedures Seven dogs underwent ( R )-[ 11 C]roli...
Saved in:
Published in: | Molecular imaging and biology 2012-04, Vol.14 (2), p.225-236 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
(
R
)-[
11
C]rolipram and (
S
)-[
11
C]rolipram have been proposed to investigate phosphodiesterase-4 and, indirectly, cAMP-mediated signaling with PET. This study assessed binding of these tracers to phosphodiesterase-4 in canine myocardium.
Procedures
Seven dogs underwent (
R
)-[
11
C]rolipram and (
S
)-[
11
C]rolipram dynamic PET imaging at baseline and with co-injection of saturating doses of (
R
)-rolipram. Dual-input compartment models were applied to estimate the volumes of distribution (
V
T
).
Results
The model comprising one compartment for unmetabolized tracer and one compartment for labeled metabolites provided excellent fits to data acquired with (
S
)-[
11
C]rolipram at baseline and with both enantiomers during co-injection scans. Use of two compartments for unmetabolized (
R
)-[
11
C]rolipram at baseline was warranted according to Akaike and Schwarz criteria.
V
T
estimates obtained with these models were robust (CV ≤ 8.2%) and reproducible (CV ≤ 15%).
Conclusion
An important fraction (~65%) of the
V
T
of (
R
)-[
11
C]rolipram at baseline reflects specific binding. Thus, the latter may be a useful index of phosphodiesterase-4 levels in canine myocardium. |
---|---|
ISSN: | 1536-1632 1860-2002 |
DOI: | 10.1007/s11307-011-0482-6 |